Guillain‐Barré syndrome following COVID‐19 vaccination: An updated systematic review of cases

<h3>Key Clinical Message</h3><p dir="ltr">Guillain‐Barré syndrome (GBS) is a rare but possible complication that may occur after COVID‐19 vaccination. In this systematic review, we found that GBS presented in patients with an average age of 58. The average time for sympto...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Nour Shaheen (14034758) (author)
مؤلفون آخرون:	Abdelraouf Ramadan (17687433) (author), Abdulqadir J. Nashwan (11659453) (author), Ahmed Shaheen (15205087) (author), Shahzaib Ahmad (16676910) (author), Karam R. Motawea (13954362) (author), Salaheldin Mohamed (21397952) (author), Rahma Sameh Mohamed (21397955) (author), Sarya Swed (12331238) (author), Hani Aiash (12324223) (author)
منشور في:	2023
الموضوعات:	Biomedical and clinical sciences Immunology Health sciences Epidemiology Public health COVID-19 COVID-19 vaccines Guillain-Barré syndrome (GBS) SARS-CoV-2
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Guillain‐Barré syndrome following COVID‐19 vaccination: An updated systematic review of cases

مواد مشابهة